A detailed history of State Street Corp transactions in 23and Me Holding Co. stock. As of the latest transaction made, State Street Corp holds 6,396,075 shares of ME stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,396,075
Previous 5,736,198 11.5%
Holding current value
$2.49 Million
Previous $5.22 Million 35.06%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.4 - $0.91 $263,950 - $600,488
659,877 Added 11.5%
6,396,075 $3.39 Million
Q4 2023

Feb 14, 2024

SELL
$0.71 - $0.97 $623,230 - $851,455
-877,789 Reduced 13.27%
5,736,198 $5.22 Million
Q3 2023

Nov 14, 2023

BUY
$0.96 - $2.01 $413,514 - $865,795
430,744 Added 6.97%
6,613,987 $6.48 Million
Q2 2023

Aug 14, 2023

BUY
$1.59 - $2.29 $917,309 - $1.32 Million
576,924 Added 10.29%
6,183,243 $10.8 Million
Q1 2023

May 15, 2023

BUY
$2.05 - $2.87 $297,159 - $416,023
144,956 Added 2.65%
5,606,319 $12.8 Million
Q4 2022

Feb 14, 2023

BUY
$2.06 - $3.47 $799,500 - $1.35 Million
388,107 Added 7.65%
5,461,363 $11.8 Million
Q3 2022

Nov 15, 2022

BUY
$2.6 - $5.12 $3.92 Million - $7.71 Million
1,506,181 Added 42.22%
5,073,256 $14.5 Million
Q2 2022

Aug 15, 2022

BUY
$2.19 - $3.98 $5.22 Million - $9.48 Million
2,382,040 Added 201.01%
3,567,075 $8.85 Million
Q1 2022

May 16, 2022

BUY
$3.28 - $7.12 $2.86 Million - $6.22 Million
873,217 Added 280.04%
1,185,035 $4.54 Million
Q4 2021

Feb 14, 2022

BUY
$6.55 - $13.25 $498,592 - $1.01 Million
76,121 Added 32.3%
311,818 $2.08 Million
Q3 2021

Nov 15, 2021

BUY
$7.29 - $11.0 $1.72 Million - $2.59 Million
235,697 New
235,697 $2.14 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $101M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.